HELICOBACTER PYLORI INFECTION. RELEVANCE OF THE PROBLEM, PREVALENCE AND RISK FACTORS
https://doi.org/10.52485/19986173_2024_4_99
Abstract
Helicobacter pylori (HP) is one of the most common infections and is recognized as a gastric pathogen in humans, leading to the development of gastritis in all infected individuals. The etiological role of HP in the formation of peptic ulcer (PU) and gastric cancer (GC) has been noted. The prevalence of HP differs in different regions, in different ethnic, social and age groups. The article summarizes publications on the frequency of HP infection in different countries, changes in the epidemiological situation in the world in recent years, and noted a decrease in HP positivity in Japan, Korea, China, and Australia. Risk factors for infection were analyzed depending on gender, age, place of residence, ethnicity, educational status and profession. Data are presented on the more frequent infection of medical personnel with HP. Identification of an occupational risk group for medical workers is an important fact, as it can contribute to the early detection and treatment of Helicobacter pylori infection and associated diseases (chronic gastritis, ulcers, gastric cancer), the prevention and control of the transmission of HP in the workplace, as well as a better understanding of the problem and proper treatment of their patients.
About the Authors
E. V. Luzina
Chita State Medical Academy
Russian Federation
Russian Federation
Luzina E.V. Doctor of Medical Sciences, associate Professor of the Department of Therapy Faculty of Additional Professional Education; Chairman of the Trans-Baikal scientific society of gastroenterologists
39а Gorky St., Chita, Russia, 672000
N. V. Lareva
Chita State Medical Academy
Russian Federation
Russian Federation
Lareva N.V., Acting rector of the FSBEI HE «Chita State Medical Academy» of the Ministry of Health of Russia, doctor of Medical Sciences, Professor, Vice-rector for research and international affairs, Head of the Department of Therapy Faculty of Additional Professional Education; Chairman of the Trans-Baikal Regional Branch of the Russian Scientific Medical Society of Internal Medicine
39а Gorky St., Chita, Russia, 672000
L. B. Lazebnik
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Lazebnik L.B., Doctor of Medical Sciences, Vice President of the RSMST, President of the GSSR, Professor of the Department of Internal Medicine and Preventive Medicine
Scopus Author ID: 7005446863
20/1 Delegatskaya St., Moscow, Russia, 127473
E. A. Tomina
Chita State Medical Academy
Russian Federation
Russian Federation
Tomina E.A., MD, PhD, associate Professor of Therapeutic Department of Postgraduate training
39а Gorky St., Chita, Russia, 672000
O. A. Lyannaya
MEDLUX multidisciplinary medical center
Russian Federation
Russian Federation
Lyannaya O.A., gastroenterologist, the head of the therapeutic department
97/1 Babushkina St., Chita, Russia, 672039
References
1. Bordin D.S., Livzan M.A., Osipenko M.F. et al. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022. 9. 5–21. DOI: 10.31146/1682-8658-ecg-205-9-5-21. in Russian.
2. Kalisperati P., Spanou E., Pateras I.S. et al. Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis. Front Genet. 2017 Feb 27. 8. 20. DOI: 10.3389/fgene.2017.00020.
3. Díaz P., Valderrama M.V., Bravo J., Quest A.F.G. Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression. Front Microbiol. 2018 Jan 22. 9. 5. DOI: 10.3389/fmicb.2018.00005.
4. Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis. 2012 Jan. 13 (1). 2–9. DOI: 10.1111/j.1751-2980.2011.00550.x.
5. Venerito M., Link A., Rokkas T., Malfertheiner P. Review: Gastric cancer-Clinical aspects. Helicobacter. 2019 Sep. 24 Suppl 1. e12643. DOI: 10.1111/hel.12643.
6. Kaprin A.D., Starinskiy V.V., Petrova G.V. (ed.) The status of cancer care for the population of Russia in 2018. M. MNROI named after P.A. Herzen, a branch of the Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia. 2019. in Russian.
7. Sugano K. Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019 May. 22 (3). 435–445. DOI: 10.1007/s10120-018-0876-0.
8. Rosenstock S., Jørgensen T., Bonnevie O., Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003 Feb. 52 (2). 186–93. DOI: 10.1136/gut.52.2.186.
9. Bordin D.S., Voynovan I.N., Kolbasnikov S.V., Embutnieks Yu.V. Diagnosis of Helicobacter pylori infection in clinical practice. Therapeutic Archive. 2018. 12. 133–139. DOI: 10.26442/00403660.2018.12.000020. in Russian.
10. Wang T., Girgis S., Chang H-J. et al. Changes in Gastric Pathology after H. pylori Treatment in Community-Driven Research Aimed at Gastric Cancer Prevention. Cancers (Basel). 2023 Aug 3. 15 (15). 3950. DOI: 10.3390/cancers15153950.
11. Mnichil Z., Nibret E., Hailegebriel T., Demelash M., Mekonnen D. Prevalence and associated risk factors of Helicobacter pylori infection in East Africa: a systematic review and meta-analysis. Braz J Microbiol. 2023 Dec 2. DOI: 10.1007/s42770-023-01190-0.
12. Leja M., Grinberga-Derica I., Bilgilier C., Steininger Ch. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019 Sep. 24 Suppl 1. e12635. DOI: 10.1111/hel.12635.
13. Laszewicz W., Iwańczak F., Iwańczak B.; Task Force of the Polish Society of Gastroenterology; Task Force of the Polish Society of Gastroenterology. Seroprevalence of Helicobacter pylori infection in Polish children and adults depending on socioeconomic status and living conditions. Adv Med Sci. 2014 Mar. 59 (1). 147–50. DOI: 10.1016/j.advms.2014.01.003.
14. Ren Sh, Cai P., Liu Y. et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022 Mar. 37 (3). 464–470. DOI: 10.1111/jgh.15751.
15. Bálint L., Tiszai A., Kozák G. et al. Epidemiologic characteristics of Helicobacter pylori infection in southeast Hungary. World J Gastroenterol. 2019 Nov 14. 25 (42). 6365–6372. DOI: 10.3748/wjg.v25.i42.6365.
16. Bai D., Liu K., Wang R. et al. Prevalence Difference of Helicobacter pylori Infection Between Tibetan and Han Ethnics in China: A Meta-analysis on Epidemiologic Studies (SIGES). Asia Pac J Public Health. 2023 Mar. 35 (2–3). 103–111. DOI: 10.1177/10105395221134651.
17. Leja M., Axon A., Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016 Sep. 21 Suppl 1. 3–7. DOI: 10.1111/hel.12332.
18. Polivanova T.V., Vshivkov V.A., Muravjeva N.G. Association of gastroduodenal diseases with Helicobacter pylori-infection in native children of Tuva and Evenkia. Children infections. 2015. 14 (2). 25–28. DOI: 10.22627/2072-8107-2015-14-2-25-28. in Russian.
19. Abiko S., Hirayama Y., Otaki J. et al. Changes in prevalence of Helicobacter pylori in Japan from 2008 to 2018: a repeated cross-sectional study. BMJ Open. 2022 Sep 8. 12 (9). e058774. DOI: 10.1136/bmjopen-2021-058774.
20. Kwon Y.J., Kim N., Baek S.M. et al. The prevalence of histologic atrophy and intestinal metaplasia in the corpus has decreased over 15 years in females in the Korean population. Helicobacter. 2019 Jun. 24 (3). e12579. DOI: 10.1111/hel.12579.
21. Congedi J., Williams C., Baldock K. L. Epidemiology of Helicobacter pylori in Australia: a scoping review. PeerJ. 2022 May 31. 10. e13430. DOI: 10.7717/peerj.13430.
22. Hooi J.K.Y., Lai W.Y., Ng W.K. et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 Aug. 153 (2). 420–429. DOI: 10.1053/j.gastro.2017.04.022.
23. Bordin D., Morozov S., Plavnik R. et al. Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real-world national multicenter trial. Helicobacter. 2022 Oct. 27 (5). e12924. DOI: 10.1111/hel.12924.
24. Kayali S., Manfredi M., Gaiani F. et al. Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Biomed. 2018 Dec 17. 89 (8-S). 72–76. DOI: 10.23750/abm.v89i8-S.7947.
25. Tarhane S., Anuk T., Sağlam A.G. et al. Helicobacter pylori Positivity and Risk Analysis in Patients with Abdominal Pain Complaints. Mikrobiyol Bul. 2019 Jul. 53 (3). 262–273. DOI: 10.5578/mb.68267.
26. Zhang F., Pu K., Wu Zh. et al. Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China. Trop Med Int Health. 2021 Mar. 26 (3). 290–300. DOI: 10.1111/tmi.13517.
27. Khoder Gh., Mina S., Mahmoud I. et al. Helicobacter pylori Infection in Tripoli, North Lebanon: Assessment and Risk Factors. Biology (Basel). 2021 Jun 28. 10 (7). 599. DOI: 10.3390/biology10070599.
28. Zhang Y., Wang Sh., Hu B. et al. Direct detection of Helicobacter pylori in biopsy specimens using a high- throughput multiple genetic detection system. Future Microbiol. 2016 Dec. 11. 1521-1534. DOI: 10.2217/fmb-2016-0149.
29. Martel C., Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Meta-Analysis Dig Dis Sci. 2006 Dec. 51 (12). 2292–301. DOI: 10.1007/s10620-006- 9210-5.
30. Plavnik R. G., Bakulina N. V., Mareyeva D. V., Bordin D. S. Helicobacter pylori Epidemiology: Clinical and Laboratory Parallels. Effective pharmacotherapy. 2019. 15 (36). 16–20. DOI: 10.33978/2307-3586-2019-15-36-16-20. in Russian.
31. Gemilyan M., Hakobyan G., Benejat L. et al. Prevalence of Helicobacter pylori infection and antibiotic resistance profile in Armenia. Gut Pathog. 2019 Jun 8. 11. 28. DOI: 10.1186/s13099-019-0310-0.
32. Chen R-X., Zhang D-Y., Zhang X. et al. A survey on Helicobacter pylori infection rate in Hainan Province and analysis of related risk factors. BMC Gastroenterol. 2023 Sep 30. 23 (1). 338. DOI: 10.1186/s12876-023-02973-3.
33. Khalifa M. M., Sharaf R. R., Aziz R. K. Helicobacter pylori: a poor man's gut pathogen? Gut Pathog. 2010 Mar 31. 2 (1). 2. DOI: 10.1186/1757-4749-2-2.
34. Kheyre H., Morais S., Ferro A. et al. The occupational risk of Helicobacter pylori infection: a systematic review. Int Arch Occup Environ Health. 2018 Aug. 91 (6). 657–674. DOI: 10.1007/s00420-018-1315-6.
35. Fan H-M., Yuan J-X., Xu Y-J., Tian L-M. Study on the determinants of Helicobacter pylori infection among coal miners. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun. 25 (6). 484-6.
36. Schryver A., Cornelis K., Van Winckel M. et al. The occupational risk of Helicobacter pylori infection among workers in institutions for people with intellectual disability. Occup Environ Med. 2008 Sep. 65 (9). 587–91. DOI: 10.1136/oem.2007.035022.
37. Schryver А.А., Van Winckel М.А. Helicobacter pylori infection: epidemiology and occupational risk for health care workers. Ann Acad Med Singap. 2001 Sep. 30 (5). 457–63.
38. Schryver А.А., Hooste W.L., Winckel M.A, Sprundel M.P. Helicobacter pylori infection: a global occupational risk for healthcare workers? Int J Occup Environ Health. 2004 Oct-Dec. 10 (4). 428–32. DOI: 10.1179/oeh.2004.10.4.428.
39. Bordin D. S., Plavnik R. G., Nevmerzhitskiy V. I. et al. Prevalence of Helicobacter pylori among medical workers in Moscow and Kazan according to ¹³С-urease breath test. Almanac of Clinical Medicine. 2018. 46 (1). 40–9. DOI: 10.18786/2072-0505-2018-46-1-40-49. in Russian.
40. Bakulina N.V., Simanenkov V.I., Bakulin I.G., Ilchishina T.A. Prevalence of helicobacter pylori infection among physicians. Experimental and Clinical Gastroenterology. 2017. 12. 20–24. in Russian.
41. Peters C., Schablon A., Harling M. et al. The occupational risk of infection among gastroenterologists and their assistants. BMC Infect Dis. 2011. 11. 154. DOI: 10.1186/1471-2334-11-154.
42. Kim H. Y., Kim N., Kim S. M. et al. Seroprevalence of Infection in Korean Health Personnel. Gut Liver. 2013. 7 (6). 648–654. DOI: 10.5009/gnl.2013.7.6.648.
Review
For citations:
Luzina E.V., Lareva N.V., Lazebnik L.B., Tomina E.A., Lyannaya O.A. HELICOBACTER PYLORI INFECTION. RELEVANCE OF THE PROBLEM, PREVALENCE AND RISK FACTORS. Transbaikalian Medical Bulletin. 2024;(4):99-108. (In Russ.) https://doi.org/10.52485/19986173_2024_4_99
Views:
149
Email this article 